Plus Therapeutics, Inc. (PSTV)
CIK 1095981 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Plus Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 10, 2026 | 8-K | 0001193125-26-387267 |
| Aug 14, 2026 | 10-Q | 0001193125-26-352444 |
| Aug 14, 2026 | 8-K | 0001193125-26-352346 |
| Aug 4, 2026 | 8-K | 0001193125-26-332939 |
| Jul 1, 2026 | 4 | 0001193125-26-292639 |
| Jul 1, 2026 | 4 | 0001193125-26-292648 |
| Jul 1, 2026 | 4 | 0001193125-26-292649 |
| Jul 1, 2026 | 4 | 0001193125-26-292642 |
| Jul 1, 2026 | 4 | 0001193125-26-292654 |
| Jul 1, 2026 | 4 | 0001193125-26-292644 |
| Jul 1, 2026 | 4 | 0001193125-26-292643 |
| Jun 18, 2026 | S-8 | 0001193125-26-275955 |
| Jun 5, 2026 | S-3/A | 0001193125-26-258388 |
| Jun 5, 2026 | 8-K | 0001193125-26-259703 |
| Jun 5, 2026 | EFFECT | 9999999995-26-001913 |
| Jun 2, 2026 | S-3 | 0001193125-26-252119 |
| May 18, 2026 | 4 | 0001193125-26-228929 |
| May 18, 2026 | 4 | 0001193125-26-228917 |
| May 18, 2026 | 4 | 0001193125-26-228919 |
| May 18, 2026 | 4 | 0001193125-26-228922 |
| May 18, 2026 | 4 | 0001193125-26-228930 |
| May 18, 2026 | 4 | 0001193125-26-228933 |
| May 18, 2026 | 4 | 0001193125-26-228926 |
| May 15, 2026 | 10-Q | 0001193125-26-226978 |
| May 15, 2026 | 8-K | 0001193125-26-226747 |